1991
DOI: 10.1097/00005344-199100189-00010
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Mild-to-Moderate Hypertension

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2010
2010
2010
2010

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Exclusion of secondary hypertension, including endocrine hypertension (mainly primary aldosteronism, but also pheochromocytoma and hypercortisolism) is recommended in these patients. Therefore the patients are switched to a drug combination of alpha 1 adrenoreceptor antagonists (A1AAs) [2,3] and/or calcium channel blockers (CCBs) [4][5][6], which does not affect plasma concentration of the endogenous hormones connected to secondary hypertension. Doxazosin and verapamil ( Fig.…”
Section: Introductionmentioning
confidence: 99%
“…Exclusion of secondary hypertension, including endocrine hypertension (mainly primary aldosteronism, but also pheochromocytoma and hypercortisolism) is recommended in these patients. Therefore the patients are switched to a drug combination of alpha 1 adrenoreceptor antagonists (A1AAs) [2,3] and/or calcium channel blockers (CCBs) [4][5][6], which does not affect plasma concentration of the endogenous hormones connected to secondary hypertension. Doxazosin and verapamil ( Fig.…”
Section: Introductionmentioning
confidence: 99%